Cassava Sciences awards $850k in discretionary bonuses to execs; CFO gets change-in-control severance

FILANA THERAPEUTICS, INC.

CEO Remi Barbier receives $500k discretionary cash bonus.
CFO Eric Schoen receives $250k bonus; employment amended to include 12-month severance after change in control.
General Counsel R. Christopher Cook and CMO James Kupiec each receive $50k bonus.
Change in control defined as acquisition of 51% or more of outstanding shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.